By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Investing > World Health Organization warns non-sugar sweeteners may increase risk of diabetes and heart disease
Investing

World Health Organization warns non-sugar sweeteners may increase risk of diabetes and heart disease

News Room
Last updated: 2023/05/15 at 8:20 AM
By News Room
Share
2 Min Read
SHARE

The World Health Organization said Monday it is advising people not to use non-sugar sweeteners for weight control, warning that they may increase the risk of Type 2 diabetes, cardiovascular diseases and mortality in adults.

The agency said a systematic review of the available evidence suggests non-sugar sweeteners do not confer any long-term benefit in reducing body fat in adults or children.  

“NSS are not essential dietary factors and have no nutritional value,” said Francesco Branca, WHO director for nutrition and food safety, in a statement. “People should reduce the sweetness of the diet altogether, starting early in life, to improve their health.”

The news was greeted with dismay by the International Sweeteners Association, with members that include PepsiCo Inc.
PEP,
+0.40%,
Celanese Corp.
CE,
-0.43%,
Cargill and Tate & Lyle PLC
TATE,
+0.86%,
among others.

“The ISA joins others, including relevant government agencies around the globe, who have responded to the public consultation on the draft guideline expressing their concerns about the conclusions and rationale used by WHO,” the association said in a statement.

“ISA agrees with the UK’s Office for Health Improvement and Disparities that commented “the guideline may go too far” and with the Australian government’s Department of Health and Aged Care who wrote that “the recommendation may result in undesirable health outcomes for some individuals.”

The WHO could only conclude a “conditional recommendation,” said the statement, because it did not include all available evidence.

That means it’s not “scientifically rigorous, nor based on a robust evidence base or supported by the evidence presented in the WHO-commissioned systematic review itself,” it added.

The new guidance applies to all people apart from those already living with diabetes, and includes all synthetic, naturally occurring or modified non-nutritive sweeteners that are not classified as sugars, including acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia and stevia derivatives, said the WHO statement.

Read the full article here

News Room May 15, 2023 May 15, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Elon Musk wants to launch a new political party. Here’s why some people think it won’t work.

Watch full video on YouTube

Why Even High Earners Are Living Paycheck To Paycheck

Watch full video on YouTube

Bank of America: Higher Yielding Preferred Stock Is Still Attractive (NYSE:BAC)

This article was written byFollowThe Investment Doctor is a financial writer, highlighting…

“Invest in what you know.”

Watch full video on YouTube

‘All the banks were lying’: Tom Hayes on his decade-long battle for justice

The last time Tom Hayes had his picture taken at London’s Southwark…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Why Home Builders Are Bouncing Today—and Why Their Stocks Are Good Buys

By News Room
Investing

This Beaten-Down Industrial Stock Wants to Call America Home. Why It’s Time to Buy.

By News Room
Investing

These 8 Dividend Aristocrats Can Protect Your Portfolio in a Downturn

By News Room
Investing

Some Lenders Benefit From SBA’s Troubled Loan Program

By News Room
Investing

Social Security Is in Turmoil. Should You Lock In Benefits Now?

By News Room
Investing

Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.

By News Room
Investing

Opinion: The stock-market selloff isn’t over yet. Here are 4 reasons why.

By News Room
Investing

With Trump’s tariffs paused, ‘Big Three’ automakers may race to build inventories

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?